Yıl: 2022 Cilt: 9 Sayı: 1 Sayfa Aralığı: 19 - 25 Metin Dili: İngilizce DOI: 10.4274/jpr.galenos.2021.46794 İndeks Tarihi: 30-06-2022

Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?

Öz:
Aim: Inflammatory bowel disease (IBD): [Crohn’s disease (CD) or ulcerative colitis (UC)] is characterised by chronic inflammation with multisystemic effects. Myocardial dysfunction may occur during active disease due to increased inflammation. The aim of our study is to evaluate the effect of disease activity index at diagnosis on myocardial functions in children with IBD in remission. Materials and Methods: The study consisted of 34 IBD patients and 21 healty children. Patients were divided into two groups according to disease activity at the diagnosis as mild and severe disease activity. Conventional echocardiography and strain echocardiography was performed for all study patients. Results: In IBD patients with severe disease activity at diagnosis, global longitudinal strain of left ventricle (GLLV), longitudinal strain (AP3) and (AP4) were lower than patients with mild disease activity at the diagnosis (p=0.043, p=0.032, p=0.028, respectively). Disease activity at the diagnosis was inversely correlated to ejection fraction (%), strain values of GLLV, left ventricle apical chamber (LVAP) 3, LVAP2 in UC patients. (p=0.047, p=0.016, p=0.029, p=0.011, respectively). Mitral E, DT was lower in IBD patients than control patients (p=0.05, p=0.04). Strain value of LVAP4 was lower in CD patients, than UC patients (p=0.046). Strain values of GLLV, LVAP3, LVAP4 was decreased in CD patients than control patients (p=0.046, p=0.046, p=0.048). Mitral E and desceleration time were found to be decreased in IBD patients than control patients (p=0.05, p=0.04 respectively). Conclusion: Our study revealed that the severity of disease activity at diagnosis has long-term effects on myocardial functions.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011; 7:235-41.
  • 2. Harbord M, Annese V, Vavricka SR, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis 2016; 10:239-54.
  • 3. Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons. World J Gastroenterol 2015; 21:9688-92.
  • 4. Gaduputi V, Tariq H, Kanneganti K. Abdominal aortitis associated with Crohn disease. Can J Gastroenterol Hepatol 2014; 28:69-70. 5. Andrade AR, Barros LL, Azevedo MFC, et al. Risk of thrombosis and mortality in inflammatory bowel disease. Clin Transl Gastroenterol 2018; 9:142.
  • 6. Hensel KO, Abellan Schneyder FE, Wilke L, Heusch A, Wirth S, Jenke AC. Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases. Sci Rep 2017; 7:2966.
  • 7. Kivrak T, Sunbul M, Cincin A, et al. Two-dimensional speckle tracking echocardiography is useful in early detection of left ventricular impairment in patients with Crohn’s disease. Eur Rev Med Pharmacol Sci 2016; 20:3249-54.
  • 8. Cincin A, Sunbul M, Kivrak T, et al. Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients. Dig Dis Sci 2014; 59:3004-11.
  • 9. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014; 58:795-806.
  • 10. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17:1314-21.
  • 11. Dotson JL, Crandall WV, Zhang P, et al. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr 2015; 60:200-4.
  • 12. Turner D, Levine A, Walters TD, et al. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease? J Pediatr Gastroenterol Nutr 2017; 64:254-60.
  • 13. Hensel KO, Wilke L, Heusch A. Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation. J Vis Exp 2016; 54736.
  • 14. Aarestrup J, Jess T, Kobylecki CJ, Nordestgaard BG, Allin KH. Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals. J Crohns Colitis 2019; 13:319-23.
  • 15. Freeman HJ, Salh B. Recurrent myopericarditis with extensive ulcerative colitis. Can J Cardiol 2010; 26:549-50.
  • 16. Uchida W, Mutsuga M, Ito H, Oshima H, Usui A. Nonbacterial Thrombotic Endocarditis Associated With Crohn Disease. Ann Thorac Surg 2018; 105:199-201.
  • 17. Efe TH, Cimen T, Ertem AG, et al. Atrial Electromechanical Properties in Inflammatory Bowel Disease. Echocardiography 2016; 33:1309-16.
  • 18. Curione M, Barbato M, Amato S, et al. Atrioventricular block associated with Crohn’s relapsing colitis in a 12-year-old child. Inflamm Bowel Dis 2010; 16:373-4.
  • 19. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn’s disease. Gastroenterology 1992; 102:1920-9.
  • 20. Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn’s disease. Relation to disease activity and response to therapy. Gut 1995; 37:805-10.
  • 21. Kjeldsen J, Rasmussen M, Schaffalitzky de Muckadell OB, Kronborg O, Junker P. Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease. Scand J Gastroenterol 2001; 36:1193-7.
  • 22. De Simone M, Cioffi U, Contessini-Avesani E, et al. Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol 2004; 4:29.
  • 23. Leidenius MH, Risteli LT, Risteli JP, Taskinen EI, Kellokumpu IH, Höckerstedt KA. Serum aminoterminal propeptide of type III procollagen (S-PIIINP) and hepatobiliary dysfunction in patients with ulcerative colitis. Scand J Clin Lab Invest 1997; 57:297-305.
  • 24. Storch I, Sachar D, Katz S. Pulmonary manifestations o inflammatory bowel disease. Inflamm Bowel Dis 2003; 9:104- 15.
  • 25. Ramos LR, Sachar DB, DiMaio CJ, Colombel JF, Torres J. Inflammatory Bowel Disease and Pancreatitis: A Review. J Crohns Colitis 2016; 10:95-104.
  • 26. Kaufman BD, Videon N, Zhang X, Harris MA, Shaddy RE, Goldmuntz E. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy. Cardiol Young 2015; 25:228-36.
  • 27. Dupuy AM, Kuster N, Curinier C, et al. Exploring collagen remodeling and regulation as prognosis biomarkers in stable heart failure. Clin Chim Acta 2019; 490:167-71.
  • 28. Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study. Circ Heart Fail 2014; 7:717-22.
  • 29. Vizzardi E, Sciatti E, Bonadei I, et al. Subclinical cardiac involvement in Crohn’s disease and ulcerative colitis: an echocardiographic case-control study. Panminerva Med 2016; 58:115-20.
  • 30. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. Gastroenterology 2003; 125:58-69.
  • 31. Roifman I, Sun YC, Fedwick JP, et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009; 7:175-82.
  • 32. Winderman R, Rabinowitz SS, Vaidy K, Schwarz SM. Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019; 68:662-8.
  • 33. Caliskan Z, Keles N, Gokturk HS, et al. Is activation in inflammatory bowel diseases associated with further impairment of coronary microcirculation? Int J Cardiol 2016; 223:176-81.
  • 34. Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2018; 16:1607-15.
APA polat e, Erolu E, Gerenli N, Ayyildiz Civan H (2022). Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. , 19 - 25. 10.4274/jpr.galenos.2021.46794
Chicago polat esra,Erolu Elif,Gerenli Nelgin,Ayyildiz Civan Hasret Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. (2022): 19 - 25. 10.4274/jpr.galenos.2021.46794
MLA polat esra,Erolu Elif,Gerenli Nelgin,Ayyildiz Civan Hasret Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. , 2022, ss.19 - 25. 10.4274/jpr.galenos.2021.46794
AMA polat e,Erolu E,Gerenli N,Ayyildiz Civan H Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. . 2022; 19 - 25. 10.4274/jpr.galenos.2021.46794
Vancouver polat e,Erolu E,Gerenli N,Ayyildiz Civan H Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. . 2022; 19 - 25. 10.4274/jpr.galenos.2021.46794
IEEE polat e,Erolu E,Gerenli N,Ayyildiz Civan H "Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?." , ss.19 - 25, 2022. 10.4274/jpr.galenos.2021.46794
ISNAD polat, esra vd. "Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?". (2022), 19-25. https://doi.org/10.4274/jpr.galenos.2021.46794
APA polat e, Erolu E, Gerenli N, Ayyildiz Civan H (2022). Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. The Journal of Pediatric Research, 9(1), 19 - 25. 10.4274/jpr.galenos.2021.46794
Chicago polat esra,Erolu Elif,Gerenli Nelgin,Ayyildiz Civan Hasret Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. The Journal of Pediatric Research 9, no.1 (2022): 19 - 25. 10.4274/jpr.galenos.2021.46794
MLA polat esra,Erolu Elif,Gerenli Nelgin,Ayyildiz Civan Hasret Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. The Journal of Pediatric Research, vol.9, no.1, 2022, ss.19 - 25. 10.4274/jpr.galenos.2021.46794
AMA polat e,Erolu E,Gerenli N,Ayyildiz Civan H Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. The Journal of Pediatric Research. 2022; 9(1): 19 - 25. 10.4274/jpr.galenos.2021.46794
Vancouver polat e,Erolu E,Gerenli N,Ayyildiz Civan H Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?. The Journal of Pediatric Research. 2022; 9(1): 19 - 25. 10.4274/jpr.galenos.2021.46794
IEEE polat e,Erolu E,Gerenli N,Ayyildiz Civan H "Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?." The Journal of Pediatric Research, 9, ss.19 - 25, 2022. 10.4274/jpr.galenos.2021.46794
ISNAD polat, esra vd. "Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?". The Journal of Pediatric Research 9/1 (2022), 19-25. https://doi.org/10.4274/jpr.galenos.2021.46794